Feature | February 16, 2009

Guidelines Encourage Use of Breast MRI for Diagnosing Breast Cancer

February 17, 2009 - Updated guidelines of best practices identify using magnetic resonance imaging (MRI) to newly diagnose breast cancer and to make treatment decisions for breast cancer as a best practice, but not as a substitute for screening or diagnostic mammography.
Breast radiologists and surgeons at the Seattle Cancer Care Alliance (SCCA) and the Roswell Park Cancer Institute in Buffalo, NY, authored the paper upon which the guidelines are based, which was published in the Journal of the National Comprehensive Cancer Network.
The SCCA breast imaging program led by Connie Lehman, M.D., has established itself as a national leader in breast MRI based on pioneering research it has published in the past few years. Lehman is corresponding author of today’s journal paper, "Indications for Breast MRI in the Patient with Newly Diagnosed Breast Cancer." The study summarizes an extensive review of published, peer-reviewed studies.
Among the key recommendations:
- MRI is not a substitute for screening or diagnostic mammography and, when indicated, diagnostic breast ultrasound. MRI supplements the use of these standard imaging tools in appropriately selected clinical situations.

- For women with diagnosed breast cancer, MRI provides enhanced detection in both the breast known to have cancer and the opposite, or “contralateral,” breast.

- Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer. Suspicious lesions should be biopsied before a surgery plan is devised in order to avoid surgical overtreatment.

- In the rare instances where cancer is found in the lymph nodes but not the breast, an MRI can find the location of cancer in the breast in nearly 60 percent of women.
“Exciting research over the past decade makes it clear that breast MRI finds cancers that are missed by mammography and ultrasound,” said Lehman, who is the director of radiology at the SCCA and a professor at the University of Washington School of Medicine. “The next phase of research is to understand more completely the impact of this improved cancer detection on treatment outcomes.”
The journal is published by the National Comprehensive Cancer Network, a non-profit alliance of 21 of the country’s leading cancer centers. Cancer guidelines published by the NCCN are the most widely used in oncology practice throughout the world. The SCCA is a member.
Coauthor of the study is Benjamin Anderson, M.D., a professor of surgery at the University of Washington and director of the SCCA’s Breast Health Clinic.
“Healthcare policy decisions regarding the use of important but expensive technology must be based upon evidence that these tools are providing measurable benefit to patients,” Anderson said. “This study provides that evidence for breast MRI.”
Breast MRI is a relatively new clinical tool for detecting breast cancer and techniques for using the sensitive equipment vary by site. Lehman and colleagues urge that clear standards for technical parameters be established, as well as performance measures at clinical sites that offer MRI.
The MRI guidelines adopted by the NCCN state that MRI examinations should be performed and interpreted by an expert breast-imaging team working in concert with a multidisciplinary diagnosis and treatment team. Breast MRI exams require dedicated equipment and breast-imaging radiologists who are familiar with the technical details for image interpretation. The NCCN guidelines also say that imaging centers need to have the ability to perform MRI-guided needle biopsy sampling of lesions detected by MRI to properly evaluate possible abnormalities.

For more information: www.seattlecca.org

Related Content

Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
MRI Plus Mammography Improves Detection of New Breast Cancer After Surgery
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

News | MRI Breast | February 21, 2017
Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at...
Rapid Breast MRI, breast cancer screening, David Strahle, RMI, Breast Cancer Research and Treatment study
News | MRI Breast | February 10, 2017
February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives
breast MRI, new AB-MR exam protocol, Via Radiology, cancer detection, dense breasts, women's health
News | MRI Breast | February 07, 2017
A newly developed breast magnetic resonance imaging (MRI) exam protocol, the first of its kind being offered in the...
News | MRI Breast | June 27, 2016
A new phase 1 clinical trial from Brigham and Women's Hospital published in Radiology on June 22 evaluated the...
breast MRI, ER-positive breast cancer detection, Case Western Reserve study

Differences in dynamic textural patterns are apparent between a patient with a low recurrence score, left, and a patient with a high recurrence score, right. Image courtesy of Nature Scientific Reports

News | MRI Breast | February 19, 2016
February 19, 2016 — A new way to analyze magnet...

Molecular imaging of the GRPR biomarker on mice xenografted with PC3 and H441 cells by T1-weighted spin echo MR imaging and NIR imaging.

News | Magnetic Resonance Imaging (MRI) | December 29, 2015
December 29, 2015 — A method to better trace changes in cancers and treatment of the prostate and lung without the li
Overlay Init